Abbott Laboratories

Latest Headlines

Latest Headlines

Abbott said to expand manufacturing, other operations in India

Abbott Laboratories wlll expand its manufacturing, as well as other operations, in India, though a dollar amount was not given by the pharmaceutical giant.

Abbott touts Japan drug-eluting Absorb stent trial results, but no approval timeline

Abbott Laboratories said a "positive" one-year clinical result in Japan comparing its dissolvable Absorb heart stent to Xience represents a milestone for the product, currently an investigational device in the country as well as the U.S. and not approved for commercial use.

Abbott bioresorbable stent comparable to its drug-eluting stent in Japanese trial

Abbott announced that its bioresorbable scaffold performed similarly to its traditional drug-eluting stent in a clinical trial for Japanese approval. The device is the market leader by far, and is already available in more than 90 countries, though not the U.S.

Citing survey, Abbott says concussion diagnostic needed

A survey conducted by Abbott concludes that most adults do not recognize common concussion symptoms.

Brand-building Abbott runs up marathon sponsorship total

Abbott, already the title sponsor of the Abbott World Marathon Majors, recently added another running sponsorship to its ever-expanding portfolio.

Abbott resigns itself to low-single-digit medical device sales growth in 2015

Despite strong contributions from fingerstick-free blood glucose monitor Freestyle Libre and mitral valve repair device MitraClip--medical devices remained the worst performing business for Abbott Laboratories last quarter as sales climbed 3.1% on an operational basis to $1.3 billion.

Abbott boosts generic drug sales by 31% in strong Q2 showing

Give a whoop for Abbott Laboratories' buyout of CFR Pharmaceuticals. That deal helped boost the company's generics sales for the second quarter to $977 million, up by 31%. The generics unit now accounts for 21% of Abbott's overall sales.

FDA approves Abbott 3-D Lasik system to improve accuracy, expand indication

The U.S. Food and Drug Administration has approved the iDesign Advanced WaveScan Studio System from Abbott Laboratories. The company has already launched the system, which is based on a 3-D map of the eye that's expected to improve the accuracy of Lasik procedures.

Top 10 pharma companies in social media

Social media success in consumer marketing has advanced beyond counting fans and followers. Today it's all about shares, retweets and links that indicate real consumer engagement with brands....

Abbott takes Pedialyte on the festival circuit as grown-up hangover remedy

Summer music festival goers may see a new face this year among the beer and souvenir tents. Pedialyte, Abbott Laboratories' electrolyte drink for sick kids, is joining the summer fun circuit to hand out samples as an antidote for overindulgence.